Barclays Maintains Underweight on Inspire Medical Systems, Lowers Price Target to $62

Benzinga · 5d ago
Barclays analyst Christopher Pasquale maintains Inspire Medical Systems (NYSE:INSP) with a Underweight and lowers the price target from $65 to $62.